Back

Related Content

We make UCL’s research physical and life sciences ideas happen.

News

News & Stories

News

Orchard Therapeutics presents additional positive data regarding MPS-IH 

News

Treatment for infantile neuroaxonal dystrophy a step closer as Bloomsbury Genetic Therapies receives Orphan Drug Designations  

News

New hope for Niemann-Pick Disease Type C treatment as Bloomsbury Genetic Therapies receives Orphan Drug Designations

News

New Alzheimer’s hope as UCLB spinout AstronauTx closes $61m Series A financing

News

UCLB spinout Orchard Therapeutics to be acquired by Kyowa Kirin for $477m

News

Bramble Energy reveals world’s ‘lowest cost’ hydrogen fuel cell

News

The Times names UCL University of the Year 2024

News

UCL partner Apollo Therapeutics receives $226.5m to translate medical research into treatments

News

Bloomsbury Genetic Therapies Receives Rare Pediatric Disease Designation from the U.S. FDA for BGT-INAD for the Treatment of Infantile Neuroaxonal Dystrophy (INAD) and Announces Upcoming Type B Pre-IND Meeting with the U.S. FDA

See more

Let’s Talk

UCLTF offers investment throughout the spinout journey. We fund proof-of-concept and development projects, and support academics with company formation. We take applications year-round.

Learn More